December 2016
Deal completed
€14M+
Revenues
Healthcare
Sector
01
Business
MedTech preclinical studies in large models
IMMR performs preclinical studies on large animals (mainly pigs and sheep) for large corporates and med-tech start-ups. The company operates on an international scale (>75% of foreign revenues in 2019). IMMR’s owns a worldwide recognition in cardiovascular research (ex: valves and stent). IMMR provides a full range of services fully compliant with the Good Laboratory Practice (GLP).
02
Strategy
Create an international leader in complex preclinical studies
IMMR will strengthen its leadership on the European market of complex preclinical studies on large models through the development of new services and the acceleration of its international expansion (mainly in USA). In the same time, IMMR will take care to maintain the highest professional standard of quality by keeping a high level of investment.
